Marek Murias Selected Research

3,4,5,4'-tetramethoxystilbene

2/2017	Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
1/2016	3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
5/2014	DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
12/2013	Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marek Murias Research Topics

Disease

28	Neoplasms (Cancer) 05/2022 - 10/2006
9	Breast Neoplasms (Breast Cancer) 05/2022 - 03/2008
4	Ovarian Neoplasms (Ovarian Cancer) 02/2017 - 05/2014
3	Carcinogenesis 01/2015 - 01/2012
3	Leukemia 02/2014 - 10/2006
2	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2019
2	Adenocarcinoma 01/2021 - 01/2016
2	Inflammation (Inflammations) 01/2019 - 01/2012
2	Hypoxia (Hypoxemia) 06/2018 - 04/2018
2	Necrosis 12/2016 - 01/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Liver Neoplasms (Liver Cancer) 07/2021
1	Chronic Hepatitis B 12/2019
1	Phototoxic Dermatitis (Phototoxicity) 04/2018
1	Eye Diseases (Eye Disease) 07/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Adenocarcinoma of Lung 01/2016
1	Angioedema 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Cough 01/2015
1	T-Cell Leukemia (Leukemia, T Cell) 02/2014
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2014
1	Colonic Neoplasms (Colon Cancer) 12/2013
1	Dehydration (Water Stress) 11/2013

Drug/Important Bio-Agent (IBA)

11	ResveratrolIBA 02/2017 - 10/2006
5	Estrogens (Estrogen)FDA Link 01/2016 - 01/2012
4	3,4,5,4'-tetramethoxystilbeneIBA 02/2017 - 12/2013
3	StilbenesIBA 01/2016 - 10/2006
3	Pharmaceutical PreparationsIBA 01/2015 - 11/2013
3	Superoxide DismutaseIBA 01/2015 - 08/2008
3	3,3',4,4',5,5'-hexahydroxystilbeneIBA 02/2014 - 10/2006
3	EnzymesIBA 11/2013 - 10/2006
2	phenethyl isothiocyanate (PEITC)IBA 12/2021 - 08/2021
2	xanthohumolIBA 12/2021 - 08/2021
2	PhytochemicalsIBA 12/2021 - 08/2021
2	Oxygen (Dioxygen)IBA 01/2021 - 06/2018
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 07/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2019
2	Biological ProductsIBA 02/2017 - 02/2010
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 02/2017 - 11/2013
2	CaspasesIBA 12/2016 - 01/2015
2	Estrogen ReceptorsIBA 01/2016 - 01/2012
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2015 - 11/2013
2	3,3',4,4'-tetrahydroxystilbeneIBA 01/2015 - 02/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2013 - 03/2011
2	3,3',4,5'-tetrahydroxystilbeneIBA 01/2012 - 12/2009
2	AntioxidantsIBA 12/2009 - 08/2008
1	SilverIBA 05/2022
1	Citric Acid (Citrate)FDA LinkGeneric 05/2022
1	EstersIBA 07/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2021
1	OximesIBA 07/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2021
1	Diclofenac (SR 38)FDA LinkGeneric 07/2021
1	Oleanolic AcidIBA 07/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021
1	AndrogensIBA 01/2021
1	HydrogelsIBA 01/2021
1	VaccinesIBA 12/2019
1	Hepatitis B Core AntigensIBA 12/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Cardiac GlycosidesIBA 01/2019
1	Cardiovascular AgentsIBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019
1	LuciferinsIBA 06/2018
1	LuciferasesIBA 06/2018
1	Liposomes (Liposome)IBA 04/2018
1	SaltsIBA 04/2018
1	ChloridesIBA 04/2018
1	phthalocyanineIBA 01/2017
1	Histones (Histone)IBA 12/2016
1	thiazolyl blueIBA 11/2016
1	physodic acidIBA 11/2016
1	AcetoneIBA 11/2016
1	Neutral RedIBA 11/2016
1	Gentian Violet (Violet, Crystal)FDA Link 11/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016
1	Parasympatholytics (Antispasmodics)IBA 01/2016
1	Estrogen Receptor alphaIBA 01/2016
1	SestrinsIBA 01/2016
1	sulforaphaneIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	CatalaseIBA 01/2015
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2015
1	p38 Mitogen-Activated Protein KinasesIBA 01/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	resazurinIBA 02/2014
1	PolyphenolsIBA 02/2014
1	Dosage Forms (Dosage Form)IBA 11/2013
1	imidaprilIBA 11/2013
1	DiketopiperazinesIBA 11/2013

Therapy/Procedure

6	Therapeutics 07/2021 - 05/2014
4	Photochemotherapy (Photodynamic Therapy) 01/2021 - 03/2015
1	Intravenous Administration 05/2022
1	Chemoprevention 01/2015